Research Papers

7 of 207 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
End-of-life care in patients with advanced lung cancer.
Lim RB.
Ther Adv Respir Dis (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Impact of the implementation of an evidence-based guideline on diagnostic testing, management, and clinical outcomes fo…
Henao-Villada R; Sossa-Briceño MP; Rodríguez-Martínez CE.
Ther Adv Respir Dis (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Nivolumab in the treatment of metastatic squamous non-small cell lung cancer: a review of the evidence.
Lim JS; Soo RA.
Ther Adv Respir Dis (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Notch signaling in lung diseases: focus on Notch1 and Notch3.
Zong D; Ouyang R; Li J; Chen Y; Chen P.
Ther Adv Respir Dis (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
High-dose beclometasone dipropionate/formoterol fumarate in fixed-dose combination for the treatment of asthma.
Corradi M; Spinola M; Petruzzelli S; Kuna P.
Ther Adv Respir Dis (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Bevacizumab in the treatment of nonsquamous non-small cell lung cancer: clinical trial evidence and experience.
Greillier L; Tomasini P; Barlesi F.
Ther Adv Respir Dis (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Early life influences on the development of chronic obstructive pulmonary disease.
Stocks J; Sonnappa S.
Ther Adv Respir Dis (Unknown)
Published: 2013
2/6 Transparent
Funding Declared